Cancer Institute A national cancer institute
designated cancer center

Philip A. Pizzo, M.D.

Publication Details

  • A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.

    Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA. N Engl J Med. 1999; 341 (5): 305-11

    Among patients with fever and neutropenia during chemotherapy for cancer who have a low risk of complications, oral administration of empirical broad-spectrum antibiotics may be an acceptable alternative to intravenous treatment.

    PubMedID: 10423464

Stanford Medicine Resources:

Footer Links: